PEMPHAGE
LIVE

Serial Number

79088959

Owner

Polyphor AG

Attorney

Scott D. Woldow

Filing Date

Sep 27, 2010

Add to watchlist:

No watchlists yet
View on USPTO

PEMPHAGE Trademark

Serial Number: 79088959 • Registration: 4095056

PEMPHAGE is a trademark filed by Polyphor AG on September 27, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Polyphor AG (8 trademarks)

Hegenheimermattweg 125
Allschwil CH4123 , CH

Entity Type: 99

Trademark Details

Filing Date

September 27, 2010

Registration Date

February 7, 2012

Published for Opposition

November 22, 2011

Cancellation Date

September 27, 2020

Goods & Services

[ Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations, namely, anticoagulants, Pharmaceutical preparations, namely, antidepressants, Pharmaceutical preparations, namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of stem cell mobilization, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical preparations for use in urology, Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in humans, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions, Pharmaceutical solutions used in dialysis, Pharmaceuticals, namely, antihelmintics, Pharmaceuticals, namely, inducers of erections, Pharmaceuticals, namely, lipid lowering agents, Pharmaceuticals, namely, psychotropics, Pharmaceuticals, namely, anti-infectives; and sanitary preparations for medical purposes; dietetic foods adapted for medical use, medical plasters, dressings for wounds, burns and surgery; dental impression materials; disinfectants for hygienic purposes ]

[ Chemicals used in industry and science ]

Scientific and technological services in the nature of scientific research in the fields of pharmaceuticals and bio-chemistry; design of new products for others in the fields of pharmaceuticals and bio-chemistry; industrial analysis, namely, quality evaluation and analysis, quality assurance, and quality control and research services in the fields of pharmaceuticals and bio-chemistry; industrial analysis, namely, industrial design in the fields of pharmaceuticals and bio-chemistry

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 7, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 7, 2021 DETH
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 7, 2021 REM4
PARTIAL INVALIDATION PROCESSED BY THE IB
Jul 26, 2019 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 18, 2019 INPS
INVALIDATION PROCESSED
May 18, 2019 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 27, 2019 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 27, 2018 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Aug 27, 2018 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 23, 2018 APRE
TEAS SECTION 71 RECEIVED
Aug 7, 2018 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Jul 19, 2018 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 7, 2017 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 30, 2013 TCCA
FINAL DECISION TRANSACTION PROCESSED BY IB
May 14, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 6, 2012 FICS
FINAL DISPOSITION PROCESSED
Jul 6, 2012 FIMP
NOTIFICATION PROCESSED BY IB
Jun 30, 2012 GPNX
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 7, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 7, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 22, 2011 NPUB
PUBLISHED FOR OPPOSITION
Nov 22, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 3, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 2, 2011 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 2, 2011 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 20, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2011 CRFA
ASSIGNED TO LIE
Oct 5, 2011 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 28, 2011 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 20, 2011 GNFN
FINAL REFUSAL E-MAILED
Jul 20, 2011 GNFR
FINAL REFUSAL WRITTEN
Jul 20, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2011 TROA
REFUSAL PROCESSED BY IB
Jan 29, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 12, 2011 RFCS
REFUSAL PROCESSED BY MPU
Jan 12, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 12, 2011 RFCR
NON-FINAL ACTION WRITTEN
Jan 11, 2011 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2011 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 23, 2010 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 19, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 18, 2010 REPR